Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trxade Group (MEDS)
NASDAQ:MEDS
Holding MEDS?
Track your performance easily
MEDS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.69 - $44.56
Previous Close$7.59
Volume18.99K
Average Volume (3M)87.47K
Market Cap
$13.28M
Enterprise Value$5.76M
Total Cash (Recent Filing)$7.72M
Total Debt (Recent Filing)$193.60K
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Jul 22, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jul 19, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-26.96
Shares Outstanding1,750,000
10 Day Avg. Volume13,624
30 Day Avg. Volume87,472
Standard Deviation0.40
R-Squared0.08
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.13
Price to Sales (P/S)3.00
Price to Cash Flow (P/CF)0.80
P/FCF Ratio0.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.52
Enterprise Value/Gross Profit2.22
Enterprise Value/Ebitda-0.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Trxade Group News
Ownership Overview
41.94% Insiders
1.37% Mutual Funds
1.44% Other Institutional Investors
55.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MEDS FAQ
What was Trxade Group’s price range in the past 12 months?
Trxade Group lowest stock price was $3.69 and its highest was $44.56 in the past 12 months.
What is Trxade Group’s market cap?
Currently, no data Available
When is Trxade Group’s upcoming earnings report date?
Trxade Group’s upcoming earnings report date is Jul 22, 2024 which is 152 days ago.
How were Trxade Group’s earnings last quarter?
Currently, no data Available
Is Trxade Group overvalued?
According to Wall Street analysts Trxade Group’s price is currently Overvalued.
Does Trxade Group pay dividends?
Trxade Group pays a Notavailable dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Trxade Group dividends here
What is Trxade Group’s EPS estimate?
Trxade Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Trxade Group have?
Trxade Group has 1,750,042 shares outstanding.
What happened to Trxade Group’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Trxade Group?
Currently, no hedge funds are holding shares in MEDS
---
Trxade Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MEDS Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Negative
Last 7 Days ▼ 1.5%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
68.06%
12-Months-Change
Fundamentals
Return on Equity
-384.13%
Trailing 12-Months
Asset Growth
296.49%
Trailing 12-Months
Company Description
Trxade Group
Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services; provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Land O' Lakes, FL.
---
MEDS Earnings Call
Q1 2023
0:00 / 0:00
---
Technical Analysis
---